Bayesian Capital Management’s Advent Technologies ADN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-567
Closed -$30.8K 750
2022
Q4
$30.8K Buy
+567
New +$35.1K ﹤0.01% 720

Other funds holding ADN

Bayesian Capital Management's ADN Position: Q1 2023 in Review

Bayesian Capital Management sold out of Advent Technologies (ADN) in Q1 2023, closing a stake of 567 shares — an estimated $30.8K sold.

Bayesian Capital Management first reported a position in ADN in Q4 2022 and held it in 1 quarter. The position peaked at $30.8K in Q4 2022. 36 funds tracked by Wall St. Rank hold ADN as of Q1 2023.

  • Bayesian Capital Management reported no remaining Advent Technologies position as of Q1 2023 after selling out during the quarter.
  • Bayesian Capital Management sold 567 Advent Technologies shares in Q1 2023, an estimated $30.8K.
  • Bayesian Capital Management first reported a position in Advent Technologies in Q4 2022 and held it in 1 quarter.
  • Bayesian Capital Management's Advent Technologies position peaked at $30.8K in Q4 2022.
  • 36 funds tracked by Wall St. Rank held Advent Technologies as of Q1 2023.

Based on Bayesian Capital Management's 13F filing for Q1 2023, filed 15 May 2023.